| Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer | Science advances |  | | 2025 | 106 | 260 |
|
| Semi-supervised integration of single-cell transcriptomics data | Nature communications | | | 2024 | 36 | 899 |
|
| Robust estimation of cancer and immune cell-type proportions from bulk tumor ATAC-Seq data | eLife | | | 2024 | 93 | 57 |
|
| Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer | Science translational medicine |  | | 2018 | 9 | 0 |
|
